Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any acute myeloid leukemia that has the chromosomal anomaly t(4;11)(q21;q23). (A chromosomal abnormality consisting of the translocation of 4q21 with 11q23.)
No clinical trials have been registered for acute myeloid leukemia, t(4;11)(q21;q23).
3 publications have been identified in PubMed for acute myeloid leukemia, t(4;11)(q21;q23). Research spans Case Report / Case Series (67%) and Gene Therapy / Novel Therapeutics (33%).
Benz T (2026). [PMID: 41145673](https://pubmed.ncbi.nlm.nih.gov/41145673/). *Leukemia*. [Gene Therapy / Novel Therapeutics]
Sayyada A (2026). [PMID: 41522563](https://pubmed.ncbi.nlm.nih.gov/41522563/). *Indian J Hematol Blood Transfus*. [Case Report / Case Series]
Lu Y (2024). [PMID: 38831789](https://pubmed.ncbi.nlm.nih.gov/38831789/). *Leuk Res Rep*. [Case Report / Case Series]
Data assembled from 2 of 12 sources · Last updated Sep 20, 2026, 6:18 AM UTC
Common questions about acute myeloid leukemia, t(4;11)(q21;q23)